Patent application number | Description | Published |
20080206712 | RESIN REINFORCED ZINC POLYCARBOXYLATE TEMPORARY CEMENT COMPOSITIONS AND RELATED KITS AND METHODS - Two-part resin-reinforced cement compositions, kits, and related methods are used for bonding a dental prosthetic appliance to a tooth. A first part includes an amine activator component and a zinc oxide reactive filler, while a second part includes a polymerization initiator (e.g., benzoyl peroxide) and a polymerizable component having a structure including at least one acrylate or methacrylate group at one end and a carboxylic acid group at another end. A temporary cement composition advantageously exhibits reduced compressive and/or bonding strength relative to permanent cement compositions, which provides sufficient strength to facilitate normal use of the teeth while the provisional appliance is in use, while also facilitating easy removal of the provisional appliance for replacement with a permanent appliance at a later time. | 08-28-2008 |
20080206715 | COLOR CHANGING DENTAL ADHESIVE COMPOSITIONS AND RELATED METHODS AND KITS - Methods, compositions, and kits for use in facilitating detection and removal of dental adhesives while minimizing and/or eliminating removal of adjacent tooth tissue. A pH sensitive color changing component (i.e., an acid/base indicator) is included within a dental adhesive composition or an activating wash composition. The adhesive composition is used to bond a dental appliance (e.g., a provisional restorative appliance or an orthodontic bracket) to a tooth. When it becomes necessary to remove the dental appliance, selective removal of the dental adhesive while minimizing and/or eliminating removal of enamel or other adjacent tooth tissue are facilitated because of the inclusion of a pH sensitive color-changing component within the dental adhesive or activating wash composition. The adhesive changes from a first color having low contrast relative to adjacent tooth tissue to a second color having greater contrast relative to adjacent tooth tissue upon application of the activating wash. | 08-28-2008 |
20090191279 | FLUORIDE VARNISH COMPOSITIONS INCLUDING AN ORGANO PHOSPHORIC ACID ADHESION PROMOTING AGENT - Fluoride varnish compositions for temporary application and adhesion to a person's teeth. The composition includes a carrier comprising a resin and an adhesion promoting agent comprising an alkyl phosphoric acid. A fluoride ion source (e.g., a fluoride salt such as sodium fluoride) is dispersed within the carrier so as to provide biologically available fluoride ions to the tooth tissue being treated. The composition adheres only temporarily to tooth tissue (e.g., for a period of at least about 4 minutes, but not more than about 1 year), after which the composition spontaneously wears away as a natural result of the action of the tongue, saliva and/or other factors. | 07-30-2009 |
20130149391 | FLUORIDE VARNISH COMPOSITIONS INCLUDING AN ORGANO PHOSPHORIC ACID ADHESION PROMOTING AGENT - Fluoride varnish compositions for temporary application and adhesion to a person's teeth. The composition includes a carrier comprising a resin and an adhesion promoting agent comprising an alkyl phosphoric acid. A fluoride ion source (e.g., a fluoride salt such as sodium fluoride) is dispersed within the carrier so as to provide biologically available fluoride ions to the tooth tissue being treated. The composition adheres only temporarily to tooth tissue (e.g., for a period of at least about 4 minutes, but not more than about 1 year), after which the composition spontaneously wears away as a natural result of the action of the tongue, saliva and/or other factors. | 06-13-2013 |
Patent application number | Description | Published |
20110137733 | METHODS FOR CAPTURING AND REPORTING METRICS REGARDING AD PLACEMENT - Systems and methods for recording impression events of Ad content on a webpage. An example method renders on a display of a computer device a webpage accessible over a network. The webpage includes at least one Ad unit. Then Ad tag information associated with the at least one Ad unit and browser viewport information (display location and size information) is retrieved. The occurrence of an Ad Placement event is determined if based on the comparison a predefined percentage of the Ad unit is within the browser viewport. An Ad Placement event timer is begun upon the determination of occurrence of the Ad Placement event. The Ad Placement event timer is stopped if an out-of-view event has occurred based on the Ad tag information and the browser viewport information. An Ad Placement event is then recorded. The recorded Ad Placement event is transmitted to a previously designated server over the network. | 06-09-2011 |
20110137737 | SYSTEMS AND METHODS FOR CAPTURING AND REPORTING METRICS REGARDING USER ENGAGEMENT INCLUDING A CANVAS MODEL - Systems and methods for capturing user engagements with Ad content included in a webpage. An example method renders a webpage having an Ad unit within a browser on a display of a user's computer. Then, a cursor event for an Ad unit included in the rendered webpage is recorded based on cursor position relative to an area on the webpage associated with the Ad unit and the recorded cursor event is transmitted to a server via a network for reporting to interested parties. The cursor event includes an initial cursor entry event, any click actions or any hover actions, and all related timings of such events. The recordation of a cursor event is further based on location information associated with the browser within the display, the webpage within the browser and the ad area within the webpage. | 06-09-2011 |
20110137925 | SYSTEMS AND METHODS FOR IDENTIFICATION AND REPORTING OF AD DELIVERY HIERARCHY - Systems and methods for determining delivery hierarchical information for an Ad unit. In an example method performed at a server, location information is received from a user computer system via a network. The location information is associated with an Ad unit presented on a webpage accessed by the user computer system. The server determines if any previously stored signature information matches with at least a portion of the received location information, then extracts domain information for any portions of the received location information that matches with any previously stored signature information. Then, at least partial delivery hierarchical information is generated based on the extracted domain information. The process repeats for other location information associated with the Ad unit that is received at the server. The generated delivery hierarchical information is aggregated. Then a report is generated based on the aggregated delivery hierarchical information. | 06-09-2011 |
Patent application number | Description | Published |
20150225438 | SUPRAMETALLOGELS AND USES THEREOF - The disclosure provides nanostructures (e.g., nanospheres and nano-paddlewheels) formed through transition metal-ligand (e.g., Pd(II)-, Ni(II)-, or Fe(II)-ligand of Formula (A)) coordination and junction self-assembly. The disclosure also provides supramolecular complexes that include the nanostructures connected by divalent linkers Y. The provided supramolecular complexes are able to form gels (e.g., hydrogels). The gels are suprametallogels and exhibited excellent mechanical properties without sacrificing self-healing and showed high robustness and storage modulus. The present disclosure further provides compositions (e.g., gels) that include the nanostructures or supramolecular complexes and optionally an agent (e.g., small molecule), where the nanostructures and the nanostructure moieties of the supramolecular complexes may encapsulate and slowly release the agent. The nanostructures, supramolecular complex, and compositions may be useful in delivering an agent to a subject, tissue, or cell, as super-absorbent materials, and in treating a disease (e.g., a genetic diseases, proliferative disease (e.g., cancer or benign neoplasm), hematological disease, neurological disease, gastrointestinal disease (e.g., liver disease), spleen disease, respiratory disease (e.g., lung disease), painful condition, genitourinary disease, musculoskeletal condition, infectious disease, inflammatory disease, autoimmune disease, psychiatric disorder, or metabolic disorder). | 08-13-2015 |
Patent application number | Description | Published |
20120300009 | COLOR IMAGE FORMING APPARATUS - Provided is a color image forming apparatus which has photosensitive members and a light irradiation unit irradiating at least one of the photosensitive members, the color image forming apparatus including: a laser driving unit causing the light irradiation unit to emit light of a light amount at a first emission level for printing when exposing an image portion and to emit light of a light amount at a second emission level for weak emission when exposing a non-image portion; an acquiring unit acquiring information of remaining lifetime of each of the photosensitive members; a first light intensity adjusting unit adjusting a first drive current to emit light at the first emission level; and a second light intensity adjusting unit adjusting a second drive current to emit light at the second emission level, the second light intensity adjusting unit changing the second drive current in accordance with the information. | 11-29-2012 |
20130328992 | IMAGE FORMING APPARATUS - An image forming apparatus including a control unit configured to cause the light irradiation unit to irradiate the photosensitive member at an image forming portion to which toner particles adhere with light emitted from the light source by a first light emission amount, and cause the light irradiation unit to irradiate the photosensitive member at a non-image forming portion to which no toner particles adhere with light emitted from the light source by a second light emission amount that is smaller than the first light emission amount. The image forming apparatus further includes an adjusting unit configured to adjust the first light emission amount and the second light emission amount, and an acquisition unit configured to acquire information relating to a speed of surface of the photosensitive member. The adjusting unit is configured to change the second light emission amount according to information acquired by the acquisition unit. | 12-12-2013 |
20140334835 | COLOR IMAGE FORMING APPARATUS - Provided is a color image forming apparatus which has photosensitive members and a light irradiation unit irradiating at least one of the photosensitive members, the color image forming apparatus including: a laser driving unit causing the light irradiation unit to emit light of a light amount at a first emission level for printing when exposing an image portion and to emit light of a light amount at a second emission level for weak emission when exposing a non-image portion; an acquiring unit acquiring information of remaining lifetime of each of the photosensitive members; a first light intensity adjusting unit adjusting a first drive current to emit light at the first emission level; and a second light intensity adjusting unit adjusting a second drive current to emit light at the second emission level, the second light intensity adjusting unit changing the second drive current in accordance with the information. | 11-13-2014 |
Patent application number | Description | Published |
20100331303 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. | 12-30-2010 |
20100331374 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. | 12-30-2010 |
20130203816 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. | 08-08-2013 |
20130245076 | PROLYL HYDROXYLASE INHIBITORS AND METHOD OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. | 09-19-2013 |
20140045899 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. | 02-13-2014 |
20140057892 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD) heart failure, ischemia, and anemia. | 02-27-2014 |
20150119425 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. | 04-30-2015 |